Biovie Inc.
BIVI· Nasdaq
Filed Feb 8, 2022 · 10-Q · 39 days after period end · 0001520138-22-000056
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$5.41M | -$3.06M | $6.67M | -$357.80K |
| EPS Diluted | -$0.22 | -$0.22 | $1.29 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 8, 2022 · 39 d after period end